title: Management of tinnitus: oral treatment with melatonin and sulodexide.
abstract: The main problem arising from tinnitus is the disturbance it causes in day-to-day life and disturbance in sleep leading to fatigue and general discomfort. We attempted to study the effect of melatonin in conjunction with Sulodexide as a treatment method for tinnitus and evaluate its effectiveness. We studied 102 patients suffering from tinnitus with a Prospective Randomised Controlled Study conducted in a tertiary care ENT department. After randomisation, 34 patients were treated with melatonin and Sulodexide, another 34 were treated with melatonin alone, and the remaining 34 (control group) were managed without therapy in order to evaluate spontaneous variations in quality of tinnitus. Patients were assessed prospectively with Tinnitus Handicap Inventory and Acufenometry both pre-treatment and post-treatment. Among the patients we studied, we found better results with both Tinnitus Handicap Inventory and Acufenometry in the group who received melatonin and Sulodexide as against melatonin alone. Any improvement was noted in the control group. In conclusion, our opinion is that melatonin in combination with Sulodexide is a viable treatment option for patients suffering from central or sensorineural tinnitus.
authors: Basic and Applied Medical Sciences Department, G. d Annunzio University of Chieti-Pescara, Chieti, Italy. gneri@unich.it
authors: G
authors: G
authors: Neri
authors: C
authors: C
authors: Baffa
authors: A
authors: A
authors: De Stefano
authors: A
authors: A
authors: Poliandri
authors: G
authors: G
authors: Kulamarva
authors: P
authors: P
authors: Di Giovanni
authors: A G
authors: AG
authors: Petrucci
authors: A
authors: A
authors: Castriotta
authors: L
authors: L
authors: Citraro
authors: D
authors: D
authors: Cerrone
authors: F
authors: F
authors: D' Orazio
authors: A
authors: A
authors: Croce
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006025:Glycosaminoglycans / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D014012:Tinnitus / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
chemical_list: D006025:Glycosaminoglycans; C007858:glucuronyl glucosamine glycan sulfate; D008550:Melatonin